MedPath

Telehealth Allied Health Care With People Who Have Parkinson's Disease Living in Rural Nevada and Wyoming

Not Applicable
Conditions
Parkinson Disease
Interventions
Behavioral: Telehealth Exercise, speech therapy, medication management
Registration Number
NCT03381898
Lead Sponsor
University of Wyoming
Brief Summary

The investigators have developed a three-part allied health care intervention to be delivered via telehealth. These interventions are usually provided face-to-face. Telehealth access to healthcare is needed for people with Parkinson's disease living in rural locations, where providers are sparse and long travel times are often not feasible because of weather conditions, as well as the hallmark symptom of Parkinson's disease, movement disorders

Detailed Description

Parkinson's Disease \& Allied Health. Parkinson's disease (PD), the second most common neurodegenerative disorder affecting more than a million people in the U.S., has no known cause or cure. Persons with PD use prescription medications and behavioral interventions to alleviate key problems such as walking, handling objects, and speaking. Individuals with PD, accessing multidisciplinary allied health care intervention, have shown functional gains. Without these ongoing, coordinated services, persons with PD become even more debilitated, and this can hasten a decline in their quality of life.

Parkinson's Disease \& Rurality. For those in rural areas, there is a critical health disparity. People who live rurally contend with isolation. Wyoming and Nevada's population density are ranked 49th and 42nd. In conjunction with this low population density and mountainous terrain, individuals experience tremendous burdens including traveling long distances to see health care providers with expertise in treating PD. These factors contribute to the struggle of rural Americans with PD to manage this complicated, chronic disease.

Parkinson's Disease \& Telehealth. Telehealth technology has successfully allowed the delivery of neurology care via "virtual house calls" with rural residents with PD. The virtual house call model was determined to be feasible and promising for specialist care in underserved rural areas. However, telehealth delivery of allied health care should also be examined.

Thus, the investigators propose an exploratory Phase 2 Behavioral Clinical Trial to determine feasibility, safety, and signal of efficacy for telehealth coordinated allied health care for persons with Parkinson's disease in rural Wyoming and Nevada. All 20 participants will be in one arm receiving telehealth exercise, speech therapy, and medication management for eight weeks.

Specific Aims:

For persons with Parkinson's disease in rural Wyoming and Nevada, the investigators will:

Aim 1 Test the feasibility of speech therapy, exercise therapy and medication management coordinated through telehealth.

Aim 2 Determine the safety of the coordinated telehealth speech therapy, exercise therapy, and medication management.

Aim 3 Measure signal of efficacy for telehealth outcomes

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Speak English
  • Are 30 years or older
  • Have been diagnosed with Parkinson's Disease by a primary care provider
  • Allow for us to communicate about you to your primary care provider (i.e., physician, nurse practitioner, or physician assistant)
  • Can stand alone for 10 min without holding on to anything
  • Are taking at least one medication for Parkinson's Disease
  • Are willing the participate in an 8-week study
  • Will provide your physical address, your phone number, and an emergency contact's phone number for us to use if an emergency occurs during your telehealth session.
Exclusion Criteria
  • Have dementia or problems following directions
  • Have a medical diagnosis that would limit exercises
  • have experienced a fall that required physician evaluation (Emergency Department, urgent care or a hospitalization) within the past year
  • Requires an assistive device or person (e.g., cane or walker) for walking, standing, balancing
  • Currently use a structured exercise regimen defined as participation in a regular exercise program consisting of more than 60 minutes per week in total

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Telehealth Coordinated Allied HealthTelehealth Exercise, speech therapy, medication managementrural persons with Parkinson's disease will receive telehealth exercise, speech therapy, medication management for 8 weeks. Exercise, speech therapy, and medication management are usual care for persons with Parkinson's disease. Having the 3 areas coordinated in delivery via telehealth is the new delivery that our aims address
Primary Outcome Measures
NameTimeMethod
Aim 3: Change in Signal of efficacy of the telehealth program - overall0, 8, 24 weeks

The change in quality of life between baseline at the beginning of the study and after the 8 week intervention. In addition, change will also be measured between the end of the 8 week intervention and 18 weeks later (24 weeks from the baseline). This quality of life measures is a self-report, PD-specific Parkinson's Disease Questionnaire 39 (PDQ39). There are 39 items in 8 subsections (mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication, bodily discomfort). Each item ranges from 0 (never) to 4 (always). The overall score and subsection scores are calculated by taking the means of each item divided by the total for that section; thus, converting the score into a percentage with higher percentages equating to more disability.

Aim 1: Feasibility of the 8-week telehealth program8 weeks

The number of sessions completed and ability to use the necessary technology.

Aim 2: Safety of the 8-week telehealth program8 weeks

The frequency and nature of adverse events during participation of the telehealth program.

Secondary Outcome Measures
NameTimeMethod
Aim 3: Signal of efficacy of the telehealth program - physical therapy 10, 8, 24 weeks

Change in 30 second Sit-to-Stand test which measures how many times the participant can stand in 30 seconds.

Aim 3: Signal of efficacy of the telehealth program - pharmacy8, 24 weeks

Change in pill count (i.e., how many pills of each prescription are taken) over the period of the study.

Aim 3: Signal of efficacy of the telehealth program - physical therapy 20, 8, 24 weeks

Change in Parkinson's Fatigue Scale, which is a self-report measure of fatigue. This scale measures 16 items using a Likert scale with a low score of 16 (low fatigue) and a high score of 80 (high fatigue).

Aim 3: Signal of efficacy of the telehealth program - speech therapy 10, 8, 24 weeks

Change in self-report Communication Effectiveness Scale, which is an 8 question scale using a 4-point likert scale on how the participant social participation is affected by his speech and communication. The scores range from 0 (not effective) to 32 (very effective communication in all situations).

Aim 3: Signal of efficacy of the telehealth program - physical therapy 30, 8, 24 weeks

Change in Unified Parkinson's Disease Rating Scale II (UPDRS II), which is a self-report of PD-specific motor aspects of experiences of daily living. There are 13 items with scores ranging from 0 (normal) to 4 (severe). Thus, a score of 0 indicates normal function whereas a score of 52 (the highest possible score) suggestive of severe motor deficits with activities of daily living.

Aim 3: Signal of efficacy of the telehealth program - speech therapy 20, 8, 24 weeks

Change in Vocal sound level intensity using the Lee Silverman Voice Treatment (LSVT) Companion Software which measures speech intensity. Changes in vocal sound level could range from - 6 decibel (dB) (reduced loudness) to at least + 6dB which is the average change and is perceptually noticeable.

Trial Locations

Locations (2)

University of Nevada Las Vegas

🇺🇸

Las Vegas, Nevada, United States

University of Wyoming

🇺🇸

Laramie, Wyoming, United States

© Copyright 2025. All Rights Reserved by MedPath